Rudy S. Suidan, MD
Pelvic Reconstruction Clinical Research Fellow
Memorial Sloan Kettering Cancer Center
Memorial Sloan-Kettering Cancer Center
1275 York Avenue, H-1206
New York,
NY
USA
10065
Papers:
21
A multicenter assessment of the ability of preoperative computed tomography scan and serum CA-125 to predict gross residual disease at primary debulking surgery for advanced ovarian, fallopian tube and peritoneal cancer
91
A multicenter prospective assessment of surgical findings associated with suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube and peritoneal cancer
104
Improvement in rates of cytoreduction to no residual for stages IIIB-IV ovarian, fallopian tube and primary peritoneal cancer: a change in surgical approach and individualized surgeon feedback
302
Outcomes for patients with advanced epithelial ovarian cancer treated with adjuvant chemotherapy at a regional network facility compared to the central campus
446
Predictive value of the age-adjusted Charlson comorbidity index on perioperative complications and survival in patients undergoing surgery for advanced ovarian cancer